Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARIA CHRISTINA DALL'ERA

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1467417980
CMS profile
404817
Location
SAN FRANCISCO, CA

General Payments · PY2018–2024

$361,812.42

  • Reported across 249 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$51,230.89

27 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $44,538.00 20
Travel and Lodging $6,571.07 5
Food and Beverage $103.82 1
Education $18.00 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $11,933.57 6
Janssen Research & Development, LLC $9,660.00 6
Aurinia Pharma U.S., Inc. $8,250.00 3
AstraZeneca UK Limited $7,518.00 4
Acerta Pharma LLC $5,388.00 2
E.R. Squibb & Sons, L.L.C. $4,863.82 4
Biogen, Inc. $2,180.00 1
F. Hoffmann-La Roche AG $1,437.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $22,415.55 23
PY2019 $31,819.42 24
PY2020 $54,066.70 42
PY2021 $57,960.75 35
PY2022 $78,654.81 43
PY2023 $65,664.30 55
PY2024 $51,230.89 27

Payment records · PY2024 (27)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $18.00 05/30/2024 Education Undisputed 01/23/2026 1104712997 CMS
AstraZeneca Pharmaceuticals LP $5,370.00 10/07/2024 Consulting Fee Undisputed 01/23/2026 1104414499 CMS
AstraZeneca UK Limited $4,027.50 05/22/2024 Consulting Fee Undisputed 01/23/2026 1093964963 CMS
AstraZeneca UK Limited $1,879.50 06/12/2024 Consulting Fee Undisputed 01/23/2026 1093885395 CMS
AstraZeneca UK Limited $1,074.00 12/20/2024 Consulting Fee Undisputed 01/23/2026 1093903710 CMS
AstraZeneca UK Limited $537.00 12/20/2024 Consulting Fee Undisputed 01/23/2026 1093970344 CMS
Aurinia Pharma U.S., Inc. $2,750.00 06/06/2024 Consulting Fee Undisputed 01/23/2026 1150678797 CMS
Aurinia Pharma U.S., Inc. $2,750.00 08/19/2024 Consulting Fee Undisputed 01/23/2026 1150678799 CMS
Aurinia Pharma U.S., Inc. $2,750.00 12/05/2024 Consulting Fee Undisputed 01/23/2026 1150678801 CMS
Biogen, Inc. $2,180.00 11/25/2024 Consulting Fee Undisputed 01/23/2026 1104844146 CMS
E.R. Squibb & Sons, L.L.C. $103.82 07/10/2024 Food and Beverage Undisputed 01/23/2026 1101335815 CMS
E.R. Squibb & Sons, L.L.C. $280.00 08/26/2024 Consulting Fee Undisputed 01/23/2026 1101335813 CMS
E.R. Squibb & Sons, L.L.C. $2,240.00 10/17/2024 Consulting Fee Undisputed 01/23/2026 1101335827 CMS
E.R. Squibb & Sons, L.L.C. $2,240.00 12/17/2024 Consulting Fee Undisputed 01/23/2026 1101335841 CMS
F. Hoffmann-La Roche AG $1,437.50 10/29/2024 Consulting Fee Undisputed 01/23/2026 1133060541 CMS
GlaxoSmithKline, LLC. $5,362.50 01/18/2024 Consulting Fee Undisputed 01/23/2026 1116562948 CMS
GlaxoSmithKline, LLC. $5,400.48 01/31/2024 Travel and Lodging Undisputed 01/23/2026 1116194654 CMS
GlaxoSmithKline, LLC. $30.64 04/24/2024 Travel and Lodging Undisputed 01/23/2026 1116075452 CMS
GlaxoSmithKline, LLC. $712.63 04/24/2024 Travel and Lodging Undisputed 01/23/2026 1116540337 CMS
GlaxoSmithKline, LLC. $396.68 04/29/2024 Travel and Lodging Undisputed 01/23/2026 1116492713 CMS
GlaxoSmithKline, LLC. $30.64 04/29/2024 Travel and Lodging Undisputed 01/23/2026 1116563980 CMS
Janssen Research & Development, LLC $1,150.00 02/08/2024 Consulting Fee Undisputed 01/23/2026 1077590283 CMS
Janssen Research & Development, LLC $2,300.00 04/18/2024 Consulting Fee Undisputed 01/23/2026 1077590287 CMS
Janssen Research & Development, LLC $920.00 05/31/2024 Consulting Fee Undisputed 01/23/2026 1077590279 CMS
Janssen Research & Development, LLC $2,300.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1077590281 CMS
Janssen Research & Development, LLC $1,380.00 10/23/2024 Consulting Fee Undisputed 01/23/2026 1077590285 CMS
Janssen Research & Development, LLC $1,610.00 12/16/2024 Consulting Fee Undisputed 01/23/2026 1077590289 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.